Lance Willsey - 26 May 2022 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 May 2022, 20:24:45 UTC
Prior SEC filing
13 May 2022
Next SEC filing
14 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nina Ayer, Attorney in Fact

Key filing fact

Lance Willsey filed Form 4 for EXELIXIS, INC. (EXEL) on 27 May 2022.

Key facts

  • This page summarizes Lance Willsey's Form 4 filing for EXELIXIS, INC. (EXEL).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 27 May 2022, 20:24.

Change

  • Previous filing in this sequence was filed on 13 May 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXEL transaction Derivative

Option (right to buy)

Award

Transaction value
$0
Shares
+42,422
Change %
Price
$0.000000
Shares after
42,422
Date
26 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
42,422
Exercise price
$18.19
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date.

SEC remarks

Exhibit List: Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .